SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures)NQF 0070 (Additional) - Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)

NQF 0070 (Additional) - Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)

Measure: NQF 0070 (Additional Measure)

Measure Title: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)

Measure description: Percentage of patients aged 18 years and older with a diagnosis of CAD and prior MI who were prescribed beta-blocker therapy.

Quality Measure Documentation Workflow

In Order for the Clinical Quality Measure report to generate, the following must be documented in the relevant patient's chart:

1.  Patient's must be 18 years old or older at the start of the reporting period have have at least one face-to-face encounter with the provider during the reporting period.

2.  Patients must have an appropriate diagnosis documented in the Summary Active Problems or the encounter Assessment field using one of the following ICD codes:

(410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31,  410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 412).

3.  Two documentation options:

(a)  Documentation that beta blocker therapy was prescribed.  Inserting the shortcut code "PQRIcadBB" in the encounter Plan field or Summary Interventions field will allow the user to select from a group of specific SMARText codes that can be used to document for this measure.  The encounter Plan field or Summary Interventions field must include any one of the CPT codes listed below: 4008F.  *Note: Legacy CPT code 4006F will also count towards this measure.

OR

(b)  Documentation that beta blocker therapy was prescribed by entering one of the following medications in the encounter Medications or Summary Medications field:

(Atenolol, Betapace, Betaxolol, Coreg, Propranolol, Inderide, Labetalol/Normodyne, Metoprolol, Nadolol, Pindolol, Acebutolol, Tenoretic, Bisoprolol).

Measure Calculation Details

Numerator Calculation:

The numerator for this measurement is calculated based on the following:

1.The number of patients in the denominator who have one of the following items documented:

(a)  The following SMARText CPT code is documented in the Summary Interventions field or the encounter Plan field: 4008F. *Note: Legacy CPT code 4006F will also increase the numerator for this measure.

OR

(b)  A beta blocker medication entered into the Summary Medications of encounter Medications field:

Beta Blocker Meds - Multum Code

Atenolol - d00004

Betapace - d00371

Betaxolol - d00176

Coreg - d03847

Propranolol - d00032

Inderide - d03261

Labetalol/Normodyne - d00016

Metoprolol - d00134

Nadolol - d00018

Pindolol - d00137

Acebutolol - d00128

Tenoretic - d03258

Bisoprolol - d00709

Denominator Calculation:

The denominator for this measurement is calculated based on the following:

1.The number of patients 18 or older at the start of the reporting period and have at least one face-to-face encounter with the provider during the reporting period;

2. And have an appropriate diagnosis in the Summary Active Problems field or encounter Assessment field:

410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 412.

Report Clinical Quality Measures to CMS/States

All of the items in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For more information on how to export the numerator, denominator, and percentage for each Clinical Quality measure, Click Here.

For more information on reporting clinical quality measures, Click Here.